Eastman Board Declares Dividend
Get Alerts EMN Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 5%
Revenue Growth %: +10.5%
Join SI Premium – FREE
KINGSPORT, Tenn., Feb.14, 2019 - The board of directors of Eastman Chemical Company (NYSE: EMN) has declared a quarterly cash dividend of $0.62 per share on the company's common stock.
The dividend is payable April 5, 2019, to stockholders of record as of March 15, 2019.
Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end-markets such as transportation, building and construction, and consumables. As a globally inclusive and diverse company, Eastman employs approximately 14,500 people around the world and serves customers in more than 100 countries. The company had 2018 revenues of approximately $10 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit www.eastman.com.
# # #
Contacts:
Media: Tracy Kilgore Addington
423-224-0498 / [email protected]
Investors: Greg Riddle
212-835-1620 / [email protected]
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eastman Chemical Company via Globenewswire
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EZ Texting Launches AI-Powered RCS Business Messaging, Delivering 7x Higher Engagement to 230,000+ Small Businesses
- Vecima to Showcase AI-Powered Broadband Access, 50G-PON Migration, and DOCSIS® 4.0 Momentum at SCTE TechExpo 2026
- Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share